JCI vs NRXPW · P/E 44, rev $23.60B vs rev $242.0K
Johnson Controls International PLC (JCI) versus NRx Pharmaceuticals Inc (NRXPW) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
NRx Pharmaceuticals Inc (NRXPW) common stock listed on NASDAQ.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Latest reported NRXPW revenue for 2025-09-30 was $242.0K. Net income was -$5.9M. NRXPW currently screens at market cap $714.6M.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. NRXPW currently screens at market cap $714.6M.
Not investment advice. Open the JCI and NRXPW stock pages for the full models.
Not investment advice.